In Depth 17 Oct 2025 NLS Days: How do things look for biotech in Sweden? As Labiotech attented the NLS Days this week, it was the occasion to learn more about the biotech industry in Sweden. October 17, 2025 - 11 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Podcast 17 Oct 2025Biotech royalty deals on the rise and here to stay In today’s episode, we welcome Clarke Futch, Chairman and CEO of HealthCare Royalty Partners, or HCRx, with a thirty year track record in biopharma investing. October 17, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Best in Biotech 15 Oct 2025 Biotech in Luxembourg: five companies that have made their name As the biotech industry in Luxembourg gradually grows, let us take a look at five biotech companies that are flourishing in the field. October 15, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 15 Oct 2025 The advent of AI for peptide design: An emerging field Discover the emerging field of AI-based peptide discovery and design – could this signal the beginning of a golden age for peptides? October 15, 2025 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 14 Oct 2025 Prader Willi syndrome: five much-anticipated therapies poised for approval The treatment drug to address insatiable hunger in people with Prader-Willi syndrome was greenlit this year. Discover five therapies in line for approval. October 14, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 13 Oct 2025 Cambridge’s biotech scene: The cornerstone of the UK’s Golden Triangle Home to a well-established hub with strong investment and startup activity, discover what makes Cambridge’s biotech scene so special. October 13, 2025 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 10 Oct 2025 Practical partnering at BIOSPAIN: on the ground with biotech innovators ready to take the next step We were on the ground in Barcelona speaking to biotech companies, university technology transfer offices, and top pharma firms about their experience at BIOSPAIN and their progress towards securing partnerships. October 10, 2025 - 8 minutesmins - By Dylan Kissane Share WhatsApp Twitter Linkedin Email
Podcast 10 Oct 2025Contraline’s ADAM in the clinic: towards a new era of male contraception? In this week’s podcast we talked with Kevin Eisenfrats, CEO of Contraline, about contraception, male contraception. October 10, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
News and Trends 9 Oct 2025 Are European biotech VCs under pressure to scale? Time to get pragmatic As Asabys Partners has rolled Aliath Bioventures into its platform, it’s worth asking if European biotech VCs are under pressure to scale. October 9, 2025 - 5 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 8 Oct 2025 Top biotech deals in September 2025 Discover the top biotech deals of September 2025, as four billion-dollar acquisitions took place and several licensing deals were signed. October 8, 2025 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 7 Oct 2025 Six companies leading the mRNA revolution in biotechnology Here are six mRNA biotechs that have raised funds in recent years to push their candidates ahead through preclinical and clinical trials. October 7, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 7 Oct 2025 AKIGAI takes EGFR inhibitors beyond cancer to treat neuropathic pain Discover how AKIGAI’s EGFR inhibitors may redefine neuropathic pain therapy and offer hope for complex regional pain syndrome (CRPS). October 7, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email